Introduction
============

Leukoaraiosis is a neuroimaging term for hyperintensities in the periventricular and subcortical white matter, thus also called white matter hyperintensities (WMH).[@b1-cia-11-065] In its progressed form, leukoaraiosis is associated with cognitive decline, functional loss, psychiatric disorders, and gait disturbance.[@b1-cia-11-065] Its prevalence increases with age and reaches almost 100% in the eighth decade.[@b2-cia-11-065] Mostly due to the association with age and cerebrovascular disease (CVD) risk factors as well as similar location as lacunar infarctions, leukoaraiosis is believed to be ischemic in origin.[@b3-cia-11-065],[@b4-cia-11-065] Since the pathophysiological mechanisms of ischemic leukoaraiosis (ILA) are poorly understood, its diagnosis is sometimes made by extensive exclusion of other radiologically similar causes of WMH that require blood tests (hypovitaminosis, thyroid disease, rheumatic disease, Fabry's disease) and invasive lumbar puncture (intracranial vasculitis, demyelination, etc).[@b1-cia-11-065],[@b3-cia-11-065] So far, there are no known confirming diagnostic tests of ILA. Because of its mortality and morbidity, early diagnosis of ILA and its prompt treatment are very important.[@b1-cia-11-065],[@b5-cia-11-065]

Ultrasound could be used as a noninvasive and easily applicable diagnostic test of ILA. It has been shown that aortic stiffness correlates with the development, progression, and degree of ILA.[@b6-cia-11-065]--[@b13-cia-11-065] By one of the theories, increased large artery stiffness causes ILA by impaired damping of the arterial wave form and reduced wave reflection at the interface of large and small arteries that expose the small vessels in the brain to abnormal pressure. Increased flow pulsations could be the cause of damage to the small vessel wall.[@b4-cia-11-065],[@b6-cia-11-065],[@b7-cia-11-065],[@b13-cia-11-065] Furthermore, it has been shown that pulsatility of the middle cerebral artery and internal carotid artery (ICA) is higher, and the blood flow velocities are lower in patients with ILA independently of carotid atherosclerosis.[@b6-cia-11-065],[@b7-cia-11-065],[@b14-cia-11-065]--[@b19-cia-11-065] Therefore, ILA could also be a consequence of the increased resistance of small arteries and hypoperfusion.[@b14-cia-11-065],[@b15-cia-11-065],[@b18-cia-11-065]--[@b21-cia-11-065] Either of the theories is hard to prove.

In our previously published studies, we found increased carotid stiffness and diminished flow through the ICAs in patients with ILA compared to CVD risk factor-matched controls.[@b22-cia-11-065],[@b23-cia-11-065] The combination of stiff large arteries with loss of the Windkessel effect and lower cerebral blood flow (CBF) could synergically cause insufficient diastolic perfusion in the deep white matter region and cause ILA. In this case, the ratio between local carotid stiffness parameters and CBF could be used as a diagnostic index of ILA. According to our knowledge, so far there are no studies on combined ultrasound markers of ILA.

The aim of this post hoc study was to compare the ratios between carotid stiffness parameters and carotid blood flow in patients with ILA to sex- and risk factor-matched control group in order to find a possible new ultrasound index of ILA.

Methods
=======

Patients with ILA (ILA group) and age-, sex-, and CVD risk factor-matched controls without ILA (control group) participated in the study. The study was approved by the National Medical Ethics Committee of the Republic of Slovenia.

The study was a post hoc analysis of our previous studies on carotid stiffness parameters and carotid hemodynamic in patients with ILA.[@b22-cia-11-065],[@b23-cia-11-065] The subjects were included in the study based on the already performed brain magnetic resonance imaging (MRI). The patients with ILA were chosen among patients who have been treated in our outpatient clinic because of ILA and were up to 65 years old. Patients with acute stroke and patients with nonlacunar strokes or any intracranial pathology other than ILA were excluded based on the MRI findings and clinical data. ILA diagnosis was based on the WMH findings on brain MRI and some additional tests excluding other causes of WMH (demyelination, vasculitis, Fabry's disease). We screened all for hypovitaminosis (vitamin B12 and folic acid), thyroid hormones, vasculitis, chronic vessel inflammation factors (C-reactive proteins, homocysteine), and rheumatoid factors. Some had additional lumbar puncture, and besides basic tests, their cerebrospinal fluid was checked for demyelinization and the presence of oligoclonal bands.

All subjects were thoroughly examined, neurological status was assessed, blood pressure was measured, body mass index was calculated, alcohol, drugs, and cigarette consumption were noted, and 12-channel electrocardiogram and laboratory blood tests (hemogram, electrolytes, four-fractioned lipidogram) were performed to define CVD risk factors and additionally exclude nonvascular causes of WMH. We also excluded patients with cardiac arrhythmia, signs of ischemic heart disease, insulin-dependent diabetes, clinical signs of stroke, and \>50% carotid artery stenosis or hemodynamically important vertebral artery stenosis.

The control group subjects were selected among patients with similar CVD risk factors and already performed brain MRI that have been treated in neurological outpatient clinics because of other symptoms such as headache and vertigo. They were chosen based on the normal brain MRI and the exclusion criteria mentioned earlier. They were thoroughly examined -- the same protocol was followed as for the ILA group.

CVD risk factors were evaluated based on a standardized interview, which included patient history, clinical examination, body mass index determination, laboratory tests, blood pressure measurement, and electrocardiography. The laboratory tests included total cholesterol, low-density lipoprotein, high-density lipoprotein, and glucose.

Experimental protocol
---------------------

The subjects were included in the study based on an already performed brain MRI. A brain MRI was performed in all patients using axial T1-weighted, T2-weighted, fluid-attenuated inversion recovery, and proton-density-weighted scans on 1.5-T MRI scanner (Signal General Electric; GEMS) in the axial and sagittal planes with the slice thickness of 5 mm. All MRI scans were evaluated by two experienced radiologists who were blinded to the ultrasound parameters, laboratory findings, and clinical variables of the study population.

All subjects gave informed consent to their participation in the study. The trial was performed in a quiet room under constant conditions. In the test preparation, each subject rested for 10--15 minutes. The mean arterial blood pressure and heart rate were measured continuously over a 5-minute interval using noninvasive plethysmography (Colin, CBM 7000).

Color-coded duplex sonography and power Doppler sonography equipped with echotracking system (Alpha 10, Aloka, Tokyo, Japan) of the carotid arteries were performed in all patients. Patients with unstable plaques of the carotid arteries and/or significant carotid artery stenosis (\>50%) according to the ultrasonographic criteria were excluded from the study. Patients with significant asymmetry of the carotid flow were further investigated and in case of intracranial pathology excluded from the study. Patients with hemodynamically important stenosis or occlusion of the extracranial vertebral arteries were also excluded.

All measurements were obtained after ≥5 minutes of rest in supine position in a quiet room with constant room temperature. We measured the blood flow velocities and diameter of both common carotid arteries (CCAs) 2 cm below the bulbus and blood flow velocity and mean diameter in both ICAs at the same place at the most clearly visible point distally from the bulbus. Average systolic, diastolic, and mean blood flow velocities, pulsatility index (PI), and resistivity index (RI) were calculated using the average values of the left and right ICA in Equations (EQs) 1--3 (ICA systolic velocity and ICA end diastolic velocity). Diastolic and systolic blood flow was calculated using EQ 4, whereas we used peek systolic and end diastolic blood flow velocities and mean diameter of ICAs. Since we used the mean diameter of ICA, the blood flows are only the approximation of the real systolic and diastolic blood flows. EQ 1. Mean velocity: (v-ICAs − v-ICAd)/3 + v-ICAd; v-ICAs: systolic velocity in ICA, v-ICAd: diastolic velocity in ICAEQ 2. PI: (v-ICAs − v-ICAd)/mean velocityEQ 3. RI: (v-ICAs − v-ICAd)/v-ICAsEQ 4. Blood flow: *Q* = *vπ*(*D*/2)[@b2-cia-11-065]; *v* = velocity, *D* = diameter of ICA.

Intima-media thickness (IMT), carotid diameter measurements, and arterial stiffness measurements were performed in the longitudinal way, strictly perpendicular to the ultrasound beam, with both walls clearly visualized bilaterally 2 cm below the bifurcation, on the far wall of the CCA. A high-quality image was acquired along a minimum of 1.5 cm length of CCA segment for reproducible measurements. IMT was measured in accordance with the Mannheim. The distance between the characteristic echoes from the lumen--intima and media--adventitia interfaces was measured. The final IMT value was based on the mean value of the three maximal IMT measurements in three frames. Arterial stiffness was automatically measured from the modification of the arterial diameter between the systolic and diastolic phases on CCA segments. Carotid diameter waveforms were assessed by means of an ultrasound and converted to carotid pressure waveforms using an empirically derived exponential relationship between pressure and arterial crosssection. Blood pressure measurements were obtained simultaneously with ultrasound measurements. The derived carotid pressure waveform was calibrated from brachial end diastolic and mean arterial pressures by iteratively changing the wall rigidity coefficient.[@b24-cia-11-065] This allowed the calculation of the arterial stiffness indices obtained as the mean value of the last six measurements: β, beta stiffness: β = ln(*Ps*/*Pd*)/(\[*Ds* − *Dd*\]/*Dd*); *Ps* and *Pd* are the systolic and diastolic pressure in mmHg, *Ds* and *Dd* are the systolic and diastolic carotid diameters, and ln is the natural logarithm.[@b25-cia-11-065]Ep (kPa), epsilon, pressure--strain elasticity modulus: Ep = (*Ps* − *Pd*)/(\[*Ds* − *Dd*\]/*Dd*).[@b25-cia-11-065],[@b26-cia-11-065]PWVβ (m/s), one-point pulse wave velocity: $\text{PWV}\beta:\sqrt{\left( {\left\lbrack {\beta \times \text{Pd}} \right\rbrack/2\rho} \right)}$; *ρ* is the blood density, *ρ* =1,050 kg/m^3^.[@b27-cia-11-065]

We then introduced new ILA indices (ILAi) that are the ratios of local carotid stiffness parameters (pulse wave velocity beta \[PWVβ\], pressure--strain elasticity modulus \[Ep\], β index) and mean and diastolic blood flows in ICA (Q-ICAm, Q-ICAd): β/Q-ICAd, Ep/Q-ICAd, PWVβ/Q-ICAd, β/Q-ICAm, Ep/Q-ICAm, and PWVβ/Q-ICAm.

Statistical analyses
--------------------

All statistical analyses were performed using SPSS 20.0 software (IBM Corporation, Armonk, NY): subject characteristics and the following ultrasound variables such as PWVβ, Ep, β index, Q-ICAd, systolic blood flow in ICA (Q-ICAs), and Q-ICAm were compared between the ILA and control group by independently paired *t*-test. The ILAi were calculated and compared between the two groups using paired *t*-test. Standardization of all the variables was made by calculation of *Z*-scores for all the ultrasound variables, and the *Z*-scores were used in all further analyses.

Correlation calculations between ultrasound parameters and ILA were performed by Spearman's correlation coefficient. Linear regression and logistic multivariate regression were used to analyze the associations between US parameters. Furthermore, logistic regression tests were used to evaluate which ultrasound parameters could predict ILA. For the evaluation of the predictive value of ultrasound parameters to identify patients with ILA, the area under the receiver operating characteristic (ROC) curve (AUC) and the corresponding 95% confidence interval (CI) were calculated. A *P*-value of \<0.05 was considered as statistically significant.

Results
=======

Fifty-two patients, aged 54.90±8.27 years, with ILA (ILA group) and 44 age-, sex-, and CVD risk factor-matched controls without ILA (control group) were included in the study. The clinical characteristics including baseline demographic data and risk factors for CVD of the ILA group and the control group are presented in [Table 1](#t1-cia-11-065){ref-type="table"}.

The parameters of the ILA patients that significantly differed from the control group in our previous studies were used for the calculation of ILAi. ILAi were therefore defined as the ratios between carotid stiffness parameters (PWVβ, Ep, β index) and blood flows in the ICA: Q-ICAd and Q-ICAm.[@b22-cia-11-065],[@b23-cia-11-065] All the ILAi were higher in the ILA group compared to the control group (*P*\<0.01), the most significant was PWVβ/Q-ICAd (*P*=0.001). The results are shown in [Table 2](#t2-cia-11-065){ref-type="table"}.

The correlations of all the ultrasound parameters with ILA are shown in [Table 3](#t3-cia-11-065){ref-type="table"}. PWVβ, Q-ICAd, Q-ICAm, and all the ILAi significantly correlated with ILA (Spearman's correlation coefficient: *r* 0.227--0.315, *P*\<0.03 for all ILAi). The results were the same when using standardized *Z*-scores of variables.

Linear regression analysis adjusted for sex, age, and all other CVD risk factors mentioned in [Table 1](#t1-cia-11-065){ref-type="table"} showed no associations between stiffness parameters and systolic, diastolic, and mean carotid blood flow. There were also no associations between mean carotid blood flow and PI and RI, whereas systolic and diastolic blood flows were independently significantly associated with PI and RI: Q-ICAs with PI-ICA: standardized *B*=0.231, *P*=0.026, CI =0.028, 0.434; Q-ICAs with RI-ICA: standardized *B*=0.233, *P*=0.024, CI =0.031, 0.436; Q-ICAd with PI-ICA: standardized *B*=−0.402, *P*\<0.001, CI =−0.593, −0.211; and Q-ICAd with RI: standardized *B*=−0.399, *P*\<0.001, CI =−0.590, −0.208.

The multivariate logistic regression model showed that PWVβ/Q-ICAd and PWVβ/Q-ICAm were the strongest independent predictors of ILA with odds ratio (OR) =9.636 for PWVβ/Q-ICAm (*P*=0.007, 95% CI =1.841, 50.443) and 4.61 for PWVβ/Q-ICAd (*P*=0.003, 95% CI =1.674, 12.743). When using standardized *Z*-scores in the analyses, the strongest was still PWVβ/Q-ICAd (OR =2.441, *P*=0.003, 95% CI =1.350, 4.412). The other results are shown in [Table 4](#t4-cia-11-065){ref-type="table"}.

For the evaluation of the diagnostic significance of ILAi for the prediction of ILA, the AUC was computed ([Table 5](#t5-cia-11-065){ref-type="table"}). The highest AUC was calculated for PWVβ/Q-ICAd (AUC =0.683, 95% CI =0.572, 0.795, *P*=0.004). The results were the same when using standardized *Z*-scores in the analyses.

Discussion
==========

The main finding of this study was that the ratios between carotid stiffness parameters and carotid blood flows were significantly higher in the ILA group compared to the risk factor-matched control group without ILA. These ratios represented as new ILAi were significant predictors of ILA. The new ultrasound indices offer a better insight into the pathophysiology of ILA. ILAi could be used as a screening test for ILA for patients with high CVD risk requiring further more expensive diagnosis including MRI. Besides, ILAi may be useful in the diagnostics of ILA possibly predicting the so-called "ischemic" etiology of WMH seen on MRI.

Our study was the first one to combine local carotid stiffness parameters and ICA blood flow in order to find useful ILAi. It is also the first study that compared ICA blood flow parameters and local carotid stiffness parameters of ILA patients to the age-, sex- and CVD risk factor-matched control group without ILA. This study is a post hoc analysis of our previous two studies.[@b22-cia-11-065],[@b23-cia-11-065] In the first study, we studied carotid stiffness parameters in patients with ILA, which had not been done previously,[@b22-cia-11-065] although they are some of the most commonly used markers of local arterial stiffness.[@b25-cia-11-065]--[@b28-cia-11-065] In the second study, blood flow velocities and flows through the carotid arteries in patients with ILA were studied. Lower flows were found, thus suggesting hypoperfusion mechanism of ILA.[@b23-cia-11-065] In both studies, we found useful carotid ultrasound indices of ILA. In this study, we combined ultrasound parameters of carotid stiffness and blood flow. Regarding general knowledge about direct influence of arterial stiffness on systolic and diastolic blood flow velocity and other hemodynamic adaptations to this, the mean blood flow should be almost independent of stiffness.[@b21-cia-11-065] However, it is not possible to exclude indirect associations between the two. For this purpose, we tested the associations between the stiffness parameters and carotid blood flow after adjustment for CVD risk factors. The linear regression and multivariate logistic regression model showed that the stiffness parameters and ICA blood flows were independently associated with ILA. Thus, we used them in the ratios as the new ILAi. All the ILAi were significantly higher in the ILA group (*P*\<0.01) and significantly correlated with ILA (*P*\<0.05). The logistic regression model showed that they are better independent predictors of ILA than carotid stiffness and blood flow parameters alone. Similarly, the diagnostic significance of ILAi tested by the ROC curves showed that ILAi are more sensitive and specific for predicting ILA (AUC \>0.600, *P*\<0.05) than carotid stiffness and blood flow parameters themselves. Therefore, the ratio between local carotid stiffness parameters and CBF could be a useful diagnostic index of ILA. Among all the ILAi, the strongest index was PWVβ/Q-ICAd, but according to the well-known influence of arterial stiffness on diastolic blood flow,[@b29-cia-11-065] the index PWVβ/Q-ICAm should be clinically more reliable. However, we have to stress out that although significant, the AUCs for all ILAi were relatively low, and the specificity and sensitivity were not high enough for diagnosing ILA by themselves. However, ILAi may be useful in predicting the ischemic etiology of leukoaraiosis seen on head MRI avoiding other more expensive and invasive diagnostic tests. Even more importantly, ILAi could possibly be used as a screening test for ILA in subjects at risk even before MRI is performed.

A major advantage of this study was the usage of the commonly available noninvasive and easily applicable ultrasound methodology. We used color-coded duplex sonography and power Doppler sonography equipped with a high-resolution B-mode echo-tracking system that enables measurements of ICA hemodynamic parameters and direct and easy determination of the local arterial stiffness parameters.[@b26-cia-11-065]--[@b29-cia-11-065] The advantages and usage of these methods were explained in our previous article.[@b22-cia-11-065],[@b23-cia-11-065]

In our previous article,[@b23-cia-11-065] we assumed that diastolic hypoperfusion was the leading mechanism of ILA. However, the PI, which was also higher in our study,[@b23-cia-11-065] and increased carotid stiffness parameters in ILA patients could both suggest another theory by which the mechanism of ILA could be a microvascular injury associated with the transmission of excessive flow pulsatility into the cerebral microcirculation due to an increased central artery stiffness and decreased wave reflection at the interface of large and small arteries.[@b4-cia-11-065],[@b6-cia-11-065],[@b7-cia-11-065],[@b13-cia-11-065] Since different theories about hemodynamic pathological mechanisms of ILA are probably not mutually exclusive, neither lower blood flow in the ICA nor the increased carotid arterial stiffness is probably enough for the development of ILA. According to our results, we assumed that the presence of the stiff large arteries in combination with the increased resistance of small arteries that lowers CBF could act synergistically and cause ILA. Since patients with ILA have higher vascular resistance,[@b6-cia-11-065],[@b7-cia-11-065],[@b14-cia-11-065]--[@b18-cia-11-065] higher mean arterial pressure is needed to obtain the same CBF.[@b21-cia-11-065] On the other hand, stiff large arteries impair the damping of the arterial waveform, and this might cause insufficient cerebral perfusion throughout diastole at the lower levels of mean arterial pressure.[@b20-cia-11-065] The significantly lower diastolic flows in patients with ILA support this theory. Therefore, the ratios between the carotid stiffness parameters and diastolic blood flow could be useful indices of ILA.

Although the underlying mechanism is not well understood, our results could be used to optimize the prevention strategies for ILA. Even though hypertension is one of the main risk factors of ILA, the patients at risk should not be treated too rigorously in order not to cause additional cerebral hypoperfusion.[@b30-cia-11-065]

Conclusion
==========

In conclusion, the new ILAi defined as the ratios between the carotid stiffness parameters and blood flow are significant predictors of ILA and have a potential diagnostic value in patients with ILA. They could be implemented as a screening tool to evaluate the risk of ILA before MRI is done. ILAi could potentially also be used in distinguishing ischemic from nonischemic causes of WMH seen on MRI. Larger studies would be necessary in order to confirm that.
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###### 

Clinical and laboratory data of the patients with ILA and controls

  Variable                       ILA group      Control group   *P*-value
  ------------------------------ -------------- --------------- -----------
  Patients (n)                   52             44              
  Age (years)                    54.90±8.27     52.39±7.34      0.118
  Male:female                    1.27±0.45      1.32±0.47       0.605
  BMI (kg/m^2^)                  30.40±4.73     30.10±5.51      0.778
  Arterial hypertension (%)      34 (0.65)      24 (0.55)       0.286
  MAP (mmHg)                     103.30±18.77   105.06±14.49    0.617
  HR (beats/min)                 61.09±11.00    62.92±9.98      0.415
  Glucose (mmol/L)               5.31±0.75      5.20±0.87       0.530
  Smoking (%)                    9 (0.17)       8 (0.18)        0.912
  Hypercholesterolemia           34 (0.65)      30 (0.68)       0.775
  Cholesterol (mmol/L)           5.03±1.18      5.28±1.12       0.299
  LDL (mmol/L)                   3.11±1.01      3.27±0.99       0.441
  HDL (mmol/L)                   1.29±0.39      1.23±0.29       0.366
  Triglycerides (mmol/L)         1.76±1.14      1.89±1.21       0.608
  Antiaggregation therapy (%)    20 (0.38)      7 (0.16)        0.012
  Antihypertensive therapy (%)   28 (0.54)      22 (0.50)       0.711
  Statin therapy (%)             15 (0.29)      11 (0.25)       0.675

**Notes:** Data are presented as mean ± standard deviation for continuous variables and number of subjects (percentage) for categorical variables and *P*-value.

**Abbreviations:** ILA, ischemic leukoaraiosis; BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HR, heart rate; MAP, mean arterial pressure.

###### 

Ultrasound parameters of carotid arterial stiffness, carotid blood flow, and ratios of carotid stiffness and blood flow in the ILA group and the control group

  Variable                  ILA group      Control group   *P*-value
  ------------------------- -------------- --------------- -----------
  β                         7.57±2.79      6.70±1.77       0.071
  Ep (kPa)                  115.91±49.07   97.97±29.73     0.038
  PWVβ (m/s)                6.47±1.23      5.94±0.87       0.017
  Q-ICAs (mm^3^/s)          10.962±2.18    11.96±2.87      0.070
  Q-ICAd (mm^3^/s)          3.50±0.88      3.98±0.80       0.008
  Q-ICAm (mm^3^/s)          5.99±1.23      6.64±1.44       0.023
  β/Q-ICAm (s/mm^3^)        1.31±0.55      1.04±0.36       0.008
  Ep/Q-ICAm (kPa s/mm^3^)   20.20±9.66     15.50±5.89      0.006
  PWVβ/Q-ICAm (mm^−2^)      1.13±0.32      0.94±0.25       0.003
  β/Q-ICAd (s/mm^3^)        2.27±1.07      1.73±0.60       0.003
  Ep/Q-ICAd (kPa s/mm^3^)   35.04±18.59    25.73±9.65      0.003
  PWVβ/Q-ICAd (mm^−2^)      1.96±0.64      1.56±0.40       0.001

**Notes:** Data are presented as mean ± standard deviation, *P*-value, and 95% confidence interval of the difference.

**Abbreviations:** ILA, ischemic leukoaraiosis; Ep, pressure--strain elasticity modulus; PWVβ, pulse wave velocity beta; β, beta index; Q-ICAs, average systolic blood flow in internal carotid arteries; Q-ICAd, average diastolic blood flow in internal carotid arteries; Q-ICAm, average mean blood flow in internal carotid arteries.

###### 

Correlations of ultrasound parameters of ILA with ILA

  Variable                  Spearman's *ρ*   *P*-value
  ------------------------- ---------------- -----------
  β                         0.149            0.153
  Ep (kPa)                  0.166            0.122
  PWVβ (m/s)                0.233            0.030
  Q-ICAd (mm^3^/s)          −0.286           0.005
  Q-ICAm (mm^3^/s)          −0.232           0.025
  β/Q-ICAm (s/mm^3^)        0.227            0.031
  Ep/Q-ICAm (kPa s/mm^3^)   0.233            0.030
  PWVβ/Q-ICAm (mm^−2^)      0.254            0.018
  β/Q-ICAd (s/mm^3^)        0.252            0.016
  Ep/Q-ICAd (kPa s/mm^3^)   0.257            0.016
  PWVβ/Q-ICAd (mm^−2^)      0.315            0.003

**Notes:** Data are presented as Spearman's rho and *P*-value. *Z*-scores of variables were used in the analyses.

**Abbreviations:** ILA, ischemic leukoaraiosis; Ep, pressure--strain elasticity modulus; PWVβ, one-point pulse wave velocity beta; β, beta index; Q-ICAd, average diastolic blood flow in internal carotid arteries; Q-ICAm, average mean blood flow in internal carotid arteries.

###### 

Associations of ultrasound parameters of ILA with ILA

  Variable                  OR      *P*-value   CI      
  ------------------------- ------- ----------- ------- -------
  β                         1.472   0.090       0.941   2.303
  Ep (kPa)                  1.607   0.055       0.990   2.610
  PWVβ (m/s)                1.712   0.028       1.061   2.762
  Q-ICAd (mm^3^/s)          0.541   0.008       0.343   0.853
  Q-ICAm (mm^3^/s)          0.577   0.016       0.368   0.902
  β/Q-ICAm (s/mm^3^)        1.848   0.016       1.120   3.050
  Ep/Q-ICAm (kPa s/mm^3^)   1.946   0.015       1.140   3.323
  PWVβ/Q-ICAm (mm^−2^)      2.009   0.007       1.207   3.343
  β/Q-ICAd (s/mm^3^)        2.152   0.010       1.204   3.847
  Ep/Q-ICAd (kPa s/mm^3^)   2.249   0.010       1.214   4.167
  PWVβ/Q-ICAd (mm^−2^)      2.441   0.003       1.350   4.412

**Notes:** Logistic regression: ILA group as a dependent variable, standardized *Z*-scores of variables were used in the analyses. Data are presented as OR, *P*-value, and 95% CI of OR.

**Abbreviations:** ILA, ischemic leukoaraiosis; OR, odds ratio; CI, confidence interval of OR; Ep, pressure--strain elasticity modulus; PWVβ, one-point pulse wave velocity beta; β, beta index; Q-ICAd, average diastolic blood flow in internal carotid arteries; Q-ICAm, average mean blood flow in internal carotid artery.

###### 

ROC analyses of ultrasound parameters of ILA

  Variable                  AUC     *P*-value   95% CI   
  ------------------------- ------- ----------- -------- -------
  β                         0.587   0.152       0.470    0.704
  Ep (kPa)                  0.597   0.121       0.478    0.715
  PWVβ (m/s)                0.636   0.031       0.518    0.753
  Q-ICAm (mm^3^/s)          0.365   0.026       0.250    0.480
  Q-ICAd (mm^3^/s)          0.333   0.006       0.224    0.443
  β/Q-ICAm (s/mm^3^)        0.632   0.032       0.518    0.747
  Ep/Q-ICAm (kPa s/mm^3^)   0.635   0.031       0.519    0.752
  PWVβ/Q-ICAm (mm^−2^)      0.648   0.019       0.532    0.764
  β/Q-ICAd (s/mm^3^)        0.647   0.017       0.534    0.760
  Ep/Q-ICAd (kPa s/mm^3^)   0.650   0.017       0.535    0.764
  PWVβ/Q-ICAd (mm^−2^)      0.683   0.004       0.572    0.795

**Notes:** Data are presented as area under ROC curve, *P*-value, and 95% CI. *Z*-scores of variables were used in the analyses.

**Abbreviations:** ILA, ischemic leukoaraiosis; AUC, area under ROC curve; ROC, receiver operating characteristic; CI, confidence interval; Ep, pressure--strain elasticity modulus; PWVβ, one-point pulse wave velocity beta; β, beta index; Q-ICAd, average diastolic blood flow in internal carotid arteries; Q-ICAm, average mean blood flow in internal carotid arteries.
